PharmaMar's shares surged 32.7% after announcing positive phase III trial results for Zepzelca, combined with Tecentriq, in treating advanced small cell lung cancer. This combination significantly...
Jazz Pharmaceuticals is a biopharmaceutical company dedicated to the development of drugs in neuroscience and oncology. Founded in 2003 in Ireland, two years later it acquired...